East Carolina University
Also known as: Assistant Professor, Department of Pharmacology and Toxicology, East Carolina University | Brody School of Medicine at East Carolina University | Dr. Michael Lang | East Carolina University | East Carolina University, Department Chair of Internal Medicine | East Carolina University - Leo W. Jenkins Cancer Center | East Carolina University School of Medicine | ECU Physicians General Internal Medicine | ECU Physicians General Internal Medicine, Psychiatry | Pitt County Memorial Hospital/Brody School of Medicine at East Carolina University | School of Dental Medicine, East Carolina University | The Brody School of Medicine at East Carolina University | xiangming fang
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1983Last known activity
Mar 27, 2024
Timeline
1900s
- Jan 1, 1907
East Carolina University— Founded
Drugs by trial phase (59 distinct, 37 trials)
Phase 4 (17 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (19 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Abscess
- Acute Pain
- Anemia
- Anemia, Sickle Cell
- Angina, Stable
- Arteriosclerosis
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Carcinoma, Non-Small-Cell Lung
- Colic
- Coronary Artery Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Emergencies
- Hematologic Diseases
- Hemoglobinopathies
- HIV Infections
- Hypertrophy
- Hypoglycemia
- Inflammation
- Ischemia
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Mitral Valve Insufficiency
- Musculoskeletal Diseases
- Musculoskeletal Pain
- Myocardial Ischemia
- Pancreatic Neoplasms
- Pneumonia
- Postoperative Pain
- Pulmonary Alveolar Proteinosis
- Renal Colic
- Renal Insufficiency
- Shock
- Shock, Septic
- Sprains and Strains
- Surgical Wound
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
- Weight Loss
Recent trials (50)
- NCT07120035Lead sponsorN/AMar 27, 2024
- NCT07120035OfficialN/AMar 27, 2024
- NCT05463783Reponsible party - principal investigatorPhase 4Jul 31, 2022
- NCT05463783Lead sponsorPhase 4Jul 31, 2022
- NCT04134403Overall official - principal investigatorPhase 3Dec 1, 2019
- NCT04160520Overall official - principal investigatorPhase 1/Phase 2Oct 28, 2019
- NCT04160520Study directorPhase 1/Phase 2Oct 28, 2019
- NCT04160520Lead sponsorPhase 1/Phase 2Oct 28, 2019
- NCT03646877CollaboratorPhase 1Oct 1, 2018
- NCT03571737Reponsible party - principal investigatorPhase 3Jun 23, 2018
- NCT03571737Lead sponsorPhase 3Jun 23, 2018
- NCT03571737Overall official - principal investigatorPhase 3Jun 23, 2018
- NCT03269994CollaboratorPhase 3Aug 28, 2017
- NCT03190785Lead sponsorN/AJul 1, 2017
- NCT03190785Reponsible party - principal investigatorN/AJul 1, 2017
Details
- Founded
- Greenville, NC, US Jan 1, 1907
- Last known activity
- Mar 27, 2024